SCHEMBL17599564

SCHEMBL17599564

Cc1cc(C)c(C)c(S(=O)(=O)Nc2cc(C3CCCCCCCCCCCCCC3C)cc3ccccc23)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ KDM4E B2RXH2 4/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ CRHBP P24387 1/20 0.44
▸ CRHR2 Q13324 1/20 0.44
▸ KEAP1 Q14145 5/20 0.41
▸ NFE2L2 Q16236 2/20 0.41
▸ GAA P10253 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ LMNA P02545 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ TAS1R3 Q7RTX0 1/20 0.34
▸ TAS1R1 Q7RTX1 1/20 0.34
▸ TAS1R2 Q8TE23 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599524 0.83 MEN1 (0.49) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599544 0.81 KDM4E (0.45) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599430 0.74 KMT2A (0.51) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599450 0.68 KEAP1 (0.66) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599535 0.68 KDM4E (0.53) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599538 0.68 KDM4E (0.53) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599530 0.67 KEAP1 (0.73) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17614106 0.67 KEAP1 (0.50) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599540 0.67 KEAP1 (0.50) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17599467 0.67 KMT2A (0.55) MEN1KMT2AKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback